Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Catalent to invest $40M in biologics facility in Durham, North Carolina

By Brian Buntz | December 15, 2022

CatalentContract manufacturing giant Catalent has announced that it will set up a new biologics analytical center of excellence in North Carolina’s Research Triangle.

The new plant will offer analytical development and testing services for biologics, including cell and gene therapies.

Catalent obtained a Job Development Investment Grant (JDIG) from the North Carolina Economic Investment Committee (EIC) to provide 201 new jobs over the next five years in Durham County.

It anticipates that construction of the facility will be completed by mid-2023.

Catalent also operates a biologics and analytical center of excellence in Kansas City, Missouri. The company has committed $12 million to expand that facility.

Earlier this month, the company announced that it had opened a sizeable commercial-scale cell therapy manufacturing facility in Gosselies, Belgium.

Additionally, it expanded a clinical supply facility in Shanghai while laying off about 600 workers at plants in the U.S.

Somerset, New Jersey–based Catalent said the new Durham, North Carolina facility would be an 80,000 ft2 facility with high-tech equipment and instrumentation. In addition, it would be outfitted with automation and digitization functionality.

Catalent saw swift growth in the early days of the pandemic until September 2021. So far this year, its stock price has fallen more than 60%, trading most recently under $46 per share. Its share price began the year at close to $120.

In 2021, the company acquired the Plano, Texas–based supplement company Bettera Holdings for $1 billion. That same year, Catalent also opened a clinical supply facility in Shiga, Japan and acquired RheinCell Therapeutics, a developer of induced pluripotent stem cells (iPSC) technologies. It also purchased the gene therapy CDMO Delphi Genetics.

The company has been a publicly traded company since 2014

Catalent was founded in April 2007 after affiliates of the Blackstone Group bought the pharmaceutical technologies and services (PTS) division of Cardinal Health.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
Thermo Fisher Scientific
Thermo Fisher to invest $2B on U.S. manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE